林培正張菡馨Pei-Cheng LinHan-Hsin Chang路承莉Angela Cheng-Li Lu醫學檢驗暨生物技術學系碩士班2026-10-159999-12-312015https://handle.ncl.edu.tw/11296/pb8cgthttps://scholars.csmu.edu.tw/handle/123456789/22091由於大量電子設備的使用、缺乏視覺保健的相關知識、視力保 護的忽視以及老化,眼睛健康成為近年來的新興議題,而在視覺保健 這個領域的研究還相當少,目前還不清楚關於視覺保健的研究進展程 度,也不明瞭其在商業上的開發程度。在本研究中,針對中華民國經 濟部智慧財產局 (Taiwan Intellectual Property Office, TIPO) 與美國專 利標商局 (United States Patent and Trademark Office, USPTO) 兩項機構 所授予專利,對可能改善視力的成分進行分析。研究開始,我們使用 專利檢索暨分析管理軟體:MTrends 去搜尋及收集相關專利,並以不 同指標分析相關專利。搜尋的關鍵字嚴格的限制在醫藥/營養/中藥/ 視覺保健成分,搜尋之年限則訂於 01/01/2005-12/31/2014 之間。我們 通過專利的數量、國家、企業、國際專利分類法的分類、以及增進視 覺保健的成分的類別來分析專利,發現 TIPO 有最少量的相關專利, 而 USPTO 擁則有大量相關的專利。取得 TIPO 相關專利的國家數目亦 較少,且只有外國公司取得,另外就專利地圖分析,以青光眼和護眼 成分專利項目為最多。這些發現指出台灣和美國護眼專利特性和市場 之差異,指出相關問題所在,並討論可能的改善方式。這些在專利分 析上的發現提供了對視覺保健研究方面新的見解,而且在增進視覺保 健的研究和投資上將有助於擬定新的方法。Eye health has been an emerging issue in the recent years, due to the heavy use of electronic devices, lack of eye-health related knowledge, ignored practice of vision protection, and aging. The field of eye health is relatively new and only small amount of studies are done. It is not clear to what extent studies related to eye health has been done, nor when it is commercially exploited. In this study, we applied patent analysis to analyze the patents granted on ocular improving agents in two different patent offices, which are Taiwan Intellectual Property Office (TIPO) and United States Patent and Trademark Office (USPTO). To start the analysis, we used a patent database program, MTrends, to search, collect related patents, and analyze the patents with different indicators. The search keywords and criteria for this patent analysis were strictly ruled to pharmaceutical composition and/or ophthalmic formulations and the search time period was from 01/01/2005 to 12/31/2014. We analyzed the patents from USPTO and TIPO by number of patents, countries, companies, and IPC. From our study, we found that TIPO have the least amount of related patents and USPTO has the most amounts of related patents. There are more countries and bigger companies issued patents in USPTO. Likewise, there are fewer countries and only foreign companies issued patents in TIPO. From patent map, glaucoma and compounds have the most issued patents. These findings based on patent analysis give us insights on the difference between the US and Taiwan eye health market through patent analysis. We found possible problems and give possible solutions. This study will help to formulate new strategies for eye health promoting researches and investments.專利專利分析促進視覺保健成分TIPOUSPTOPatentspatent analysisocular improving agents視覺保健促進成分專利分析與佈局:以美國與台灣之專利資料庫為例thesis